Abstract

Objectives: To calculate the prevalence of Hepatitis B, Hepatitis C and HIV infections in patients of myocardial infarction presenting in the emergency department. Methods: This is a longitudinal observational study.

Results: HIV, HCV and HBsAG were positive in 7 (7.0%), 4 (4.0%) and 3 (3.0%) patients respectively. Whereas both HIV and HBsAG were positive in 5 (5.0%), both HIV and HCV were positive in 1 (1.0%) patients. HCV and HBsAg co-infection was positive in none.

Conclusion: A high prevalence of Hepatitis B, Hepatitis C and HIV infections in patients is noted amongst patients of myocardial infarction reporting to emergency medicine department. This high number maybe due to an inadequate sample size or an error in a study design or a consequence of reported more prevalence in an emergency scenario.

• 1.   Singh A, Kumar M, Kumar R, Garg A, Kumar P, Singh A. Prevalence of undiagnosed HIV, hepatitis B, and hepatitis C among patients in an Indian emergency department. Emerg Med Pract. 2021;23(11):1-7.
• 2.   Bhattarai S, Thapa S, Shrestha S, Baral R, Karki S, Bhandari R, et al. Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal. PLoS One. 2018;13(10):e0205813.
• 3.   Desikan P, Khan Z. Prevalence of hepatitis B and hepatitis C virus co-infection in India: A systematic review and meta-analysis. Indian J Med Microbiol. 2017;35(3):332-9.
• 4.   Jamil M, Bhattacharya PK, Yunus M, Lyngdoh CJ, Roy A, Talukdar KK. Prevalence of hepatitis B and hepatitis C in haemodialysis population in a tertiary care centre in North Eastern India. Int J Biomed Adv Res. 2016;7:267-9.
• 5.   Malhotra R, Soin D, Grover P, Galhotra S, Khutan H, Kaur N, et al. Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: A retrospective study from a tertiary care hospital of North India. J Nat Sci Biol Med. 2016;7:72-4.
• 6.   Chawla NS, Sajiv CT, Pawar G, Pawar B. Hepatitis B and C Virus infections associated with renal replacement therapy in patients with end stage renal disease in a tertiary care hospital in India – prevalence, risk factors and outcome. Indian J Nephrol. 2005;15:205-13.
• 7.   Xess A, Kumar M, Minz S, Sharma HP, Shahi SK. Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease. Indian J Pathol Microbiol. 2001;44:253-5.
• 8.   Rajani M, Jais M. A descriptive study on prevalence, pattern and coinfection of hepatitis viruses in acute infectious hepatitis. Int J Med Public Health. 2016;6:165-9.
• 9.   Ray Saraswati L, Sarna A, Sebastian MP, Sharma V, Madan I, Thior I, et al. HIV, hepatitis B and C among people who inject drugs: High prevalence of HIV and hepatitis C RNA positive infections observed in Delhi, India. BMC Public Health. 2015;15:726.
• 10.   Devi KHS, Brajachand N, Singh HL, Singh YM. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. J Commun Dis. 2004;37:73-7.
• 11.   Kaur K, Malhotra S, Devi P, Garg PD, Sidhu S. Prevalence of HIV, HBV & HCV and their co-infections among intravenous drug users at a harm reduction centre in Amritsar: A case control study. Int J Sci Res. 2015;4:8179.
• 12.   Vandana B, Bansal A, Bansal AK, Kumar A. Seroprevalence of HBV in pregnant women and its co-infection with HCV and HIV. Int J Recent Sci Res. 2015;6:3590-3.
• 13.   Kumar R, Kaur A, Gupta S, Locham R, Kaur G. Detection and identification of occult hepatitis B virus infection among blood donors. Int J Med Sci Public Health. 2016;5:2057-61.
• 14.   Thakur V, Guptan RC, Sarin SK. Prevalence of hepatitis GB virus C/hepatitis G virus infection in blood donors in India. J Assoc Physicians India. 2000;48:818-9.
• 15.   Mohamed AS, Sawe HR, Muhanuzi B, Marombwa NR, Mjema K, Weber EJ. Non-traumatic chest pain in patients presenting to an urban emergency Department in sub Saharan Africa: A prospective cohort study in Tanzania. BMC Cardiovasc Disord. 2019;19(1):4–11.
• 16.   Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology. 2009;49(Suppl):S138-45.
• 17.   Tedaldi EM, Hullsick KH, Malvestutto CD, Arduino RC, Fisher EJ, Gaglio PJ, et al. Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials groups: The Terry Beirn Community Programs for Clinical Research on AIDS. Clin Infect Dis. 2003;36:1313-7.

Data Sharing Statement

Funding